Quest Diagnostics
455 hedge funds and large institutions have $8.05B invested in Quest Diagnostics in 2013 Q4 according to their latest regulatory filings, with 73 funds opening new positions, 151 increasing their positions, 168 reducing their positions, and 41 closing their positions.
78% more first-time investments, than exits
New positions opened: 73 | Existing positions closed: 41
7% more funds holding
Funds holding: 425 → 455 (+30)
6.49% more ownership
Funds ownership: 96.91% → 103.39% (+6.5%)
10% less repeat investments, than reductions
Existing positions increased: 151 | Existing positions reduced: 168
28% less capital invested
Capital invested by funds: $11.2B → $8.05B (-$3.17B)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
66% less call options, than puts
Call options by funds: $85.7M | Put options by funds: $252M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$183M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$97.6M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$76.9M |
| 4 |
AI
Analytic Investors
Los Angeles,
California
|
+$57.7M |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$225M |
| 2 |
AAM
Aberdeen Asset Management
Aberdeen,
United Kingdom
|
-$190M |
| 3 |
RI
Relational Investors
San Diego,
California
|
-$157M |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$99.4M |
| 5 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$64.6M |
DGX Hedge Fund Activity: Q4 2013 in Review
455 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q4 2013, worth a combined $8.05B — down 28% from $11.2B a quarter earlier.
Buyers outnumbered sellers: 73 funds opened new DGX positions and 41 closed out — a net gain of 32 holders — while 151 added to existing stakes and 168 trimmed.
The largest buyer was Bank of America, adding an estimated $183M. The largest seller was Capital World Investors, cutting an estimated $225M.
- 455 institutional investors held Quest Diagnostics (DGX) as of Q4 2013, up from 425 in Q3 2013.
- Funds reported $8.05B of Quest Diagnostics stock for Q4 2013, down 28% quarter-over-quarter.
- 73 funds opened new Quest Diagnostics positions in Q4 2013 and 41 closed out, a net change of +32 holders.
- The largest Quest Diagnostics buyer in Q4 2013 was Bank of America, an estimated $183M added.
- The largest Quest Diagnostics seller in Q4 2013 was Capital World Investors, an estimated $225M sold.
Based on aggregated 13F filings for Q4 2013.